reports
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Con...
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review - ATH434-201 Trial on Track to Complete in November 2024 – - Top-Line Data Expected in January 2025 - MELBOURNE, Australia and SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee (DMC) has completed its third...
Ladybug Signs LOI to Purchase Ecommerce Site from Your Supplement Supp...
Ladybug Signs LOI to Purchase Ecommerce Site from Your Supplement Supply Store Ltd. TULSA, Okla., May 08, 2024 (GLOBE NEWSWIRE) -- Ladybug Resource Group, Inc. (OTC PINK: LBRG), now operating under the brand name Ladybug NutraTech, is excited to announce the signing of a Letter of Intent for the acquisition of a leading e-commerce platform from Your Supplement Supply Store Ltd. This strategic move marks a significant milestone in Ladybug NutraTech's expansion and enhancement of its digital retail footprint. This e-commerce platform has been designed to serve a niche market comprising b...
Form 8.5 (EPT/RI) - Centaur Media plc
Form 8.5 (EPT/RI) - Centaur Media plc FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCentaur Media plc(c) Name of the party to the offer with which exempt principal trader is connected:Investec are Advisor and ...
- Blair Levin
WTW boosts global cyber facility with increased capacity and broader c...
WTW boosts global cyber facility with increased capacity and broader coverage options LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announces strategic enhancements to its global cyber facility. Following a successful launch in January 2023, WTW’s CyXS facility, a global solution for excess cyber insurance coverage, has introduced new features, effective 1 April 2024, designed to meet the dynamic needs of clients and keep ahead of market trends as cyber risks escalate. Key enhancements include: Increased capac...
Vishay Intertechnology Reports First Quarter 2024 Results
Vishay Intertechnology Reports First Quarter 2024 Results MALVERN, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc., (NYSE: VSH), one of the world's largest manufacturers of discrete semiconductors and passive electronic components, today announced results for the fiscal first quarter ended March 30, 2024. Highlights 1Q 2024 revenues of $746.3 millionGross margin was 22.8% and included the negative impact of 74 basis points related to the addition of NewportEPS of $0.221Q 2024 book-to-bill of 0.82 with book-to-bill of 0.73 for semiconductors and 0.91 for passive compo...
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Markus Henriksson
- Viktor Stenlöf
Eurohold Bulgaria AD: 1 director
A director at Eurohold Bulgaria AD sold 755,000 shares at 0.930BGN and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Saizeriya Company: 1 director
A director at Saizeriya Company sold 20,000 shares at 5,162.000JPY and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.